Navigation Links
Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership
Date:9/21/2009

BOZEN, Italy, September 21 /PRNewswire/ -- Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.

CytoCare is the world's first and only robotic system designed for the safe and sterile preparation of patient-specific hazardous IV Admixtures. While other companies have for many years made promises of robotic IV automation products, and even showcased marketing demonstrations of competing solutions that were supposed to exist as far back twenty years[1] ago, the fact remains that CytoCare is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous IV Admixtures, and that has been proven to work in a "live" hospital pharmacy environment, instead of just marketing brochures and trade-shows demos.

"We are thrilled to have been chosen by Health Robotics as their exclusive CytoCare partner for Oceania. CytoCare, a-one-of-its-kind solution, represents an ideal complement to our market-leading CyberKnife(R) and da Vinci(R) Surgical System robotic solutions. We are very impressed by the introductory work that a small foreign company like Health Robotics has been able to do in both Australia and New Zealand, and are eager to take the "baton" from Health Robotics and continue their work in our core markets, expanding the reach of CytoCare to other hospitals in Oceania", stated Peter Ord, CEO of Device Technologies Australia."

Device Technologies believes that CytoCare has the potential to become the gold standard for Oncology I.V. Admixtures in Oceania, equally protecting clinicians and patients. The successful installation of CytoCare at Peter McCallum Cancer Centre in Melbourne has generated a tremendous amount of interest for this revolutionary technology in both Australia and New Zealand, with the real potential to significantly improve Oceania patients' immediate access to new Oncology protocols especially outside of Sydney and Melbourne, breaking this continent's inefficient reliance on IV Outsourcing, with its inherent high cost, inconvenient logistics, and limited availability of breakthrough IV therapies for cancer patients.

"Device Technologies is the right type of strategic partner for Health Robotics in Oceania due to its well known commitment to patient safety, company stability and market footprint, world-class service infrastructure and complementary oncology surgery robotic technologies. The Device Technologies Team represents a knowledgeable, highly-skilled, committed, resourceful, and customer-focused organization, which is precisely what Health Robotics requires at this moment in time to take CytoCare to the next level of market acceptance and customer-service focus in Oceania from the initial steps we undertook with Peter McCallum Cancer Centre's installation of CytoCare at the beginning of 2009", stated Werner Rainer, CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to easing global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, visit http://www.health-robotics.com

About Device Technologies:

Device Technologies (DT) is a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand. As an independent company DT is able to source and supply the most technologically advanced medical devices and to support these with professional services and training. Device Technologies mission is to deliver superior health outcomes by providing patient access to the best medical systems available worldwide. For more information, visit http://www.device.com.au

    [1] Am J Hosp Pharm 46(11): 2286-93 1989

    For additional information, please contact:

    Health Robotics S.r.l.
    Gaspar G. DeViedma
    Via Altmann 9A, Bozen, Sud-Tyrol, I-39100
    USA: +1(609)980-7976

    EUROPE: +39(346)963-4934
    gaspar.deviedma@health-robotics.com
    Device Technologies Australia Pty Ltd.

    Mick Shaddock
    Senor Business Manager, Robotics
    +61-(03)937-1900
    mshaddock@device.com.au




'/>"/>
SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alere Executive Keynote at DMAA Conference Stresses Combining Medical and Health Improvement Models to Bring About Cost-Effective Changes in Healthcare Reform
2. Death Panel Inventor & Critic of Healthcare Reform Betsy McCaughey Has Close Ties to Philip Morris; Healthcare Industry Today Offers Complete Coverage
3. BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza
4. YourCity.MD's city health directory portals Put Local TV Broadcasters in a Position to Dominate Local Healthcare Revenues, from the Web!
5. Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health
6. Mens Health Network, The Washington Redskins and GlaxoSmithKline Team Up for Septembers Prostate Cancer Awareness Month
7. Health Plans Reduce Administrative Expenses with HEALTHsuite(R) from RAM Technologies, Inc.
8. New Poll: Americans Still Confused by President Obamas Health Care Plan -- Siegel+Gale Survey Finds Dramatic Lack of Understanding of Basic Points in Plan, Even Among Democrats
9. Statement From Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on Senator Baucus Health Care Reform Proposal
10. Back To School and Back To Important Health Basics For Youth
11. Cabot(R) Creamery Cooperatives Vermont-To-Vegas Virtual Challenge Ends On A Healthy Note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: